Hikma Pharmaceuticals Plc Director/PDMR Shareholding (7266Y)
May 19 2016 - 5:17AM
UK Regulatory
TIDMHIK
RNS Number : 7266Y
Hikma Pharmaceuticals Plc
19 May 2016
Hikma Pharmaceuticals PLC - Vesting of 2013 LTIP
LONDON, 19 May 2016: Hikma Pharmaceuticals PLC (LSE: HIK)
(NasdaqDubai: HIK) ("Hikma") announces that the following Directors
and Persons Discharging Managerial Responsibility ("PDMR") have
received shares as a result of the vesting of their conditional
share awards on 17 May 2016 under the 2005 Long Term Incentive Plan
("LTIP") which was completed on 19 May 2016. These awards were
automatically exercised by operation of the conditional award and
vesting process. The exercise price under the LTIP is GBPnil. As
indicated in the table below, certain PDMRs have made
disposals.
In accordance with DTR 3.1.2R and s.793 of the Companies Act
2006, Hikma announces that the following transactions took place in
London over Hikma's Ordinary Shares of 10p each ("Shares") as
detailed below.
PDMR Type of Shares Date Price Shares Remaining
Transaction Acquired Disposed Holding
under
LTIP
---------- ------------- ---------- ------ --------- ---------- --------------
Said Vesting 88,383 19 N/A Nil 13,265,884*
Darwazah of LTIP May
2013 2016
(0.04% (5.54%
ISC) ISC)
---------- ------------- ---------- ------ --------- ---------- --------------
Mazen Vesting 45,924 19 N/A Nil 7,256,131*
Darwazah of LTIP May
2013 2016
(0.02% (3.03%
ISC) ISC)
---------- ------------- ---------- ------ --------- ---------- --------------
Bassam Vesting 34,660 19 GBP22.42 34,660 418,658
Kanaan of LTIP May
2013 & 2016
Disposal
(0.01% (0.19%
ISC) ISC)
---------- ------------- ---------- ------ --------- ---------- --------------
Michael Vesting 32,927 19 GBP22.42 19,047 133,840
Raya of LTIP May
2013 & 2016
Disposal
(0.01% (0.06%
ISC) ISC)
---------- ------------- ---------- ------ --------- ---------- --------------
Riad Vesting 19,063 19 N/A Nil 119,090
Mishlawi of LTIP May
2013 2016
(0.01% (0.05%
ISC) ISC)
---------- ------------- ---------- ------ --------- ---------- --------------
Khalid Vesting 19,063 19 N/A Nil 221,921
Nabilsi of LTIP May
2013 2016
(0.01% (0.09%
ISC) ISC)
---------- ------------- ---------- ------ --------- ---------- --------------
Majda Vesting 14,848 19 N/A Nil 187,431
Labadi of LTIP May
2013 2016
(0.01% (0.08%
ISC) ISC)
---------- ------------- ---------- ------ --------- ---------- --------------
"ISC" = Issued Share Capital of Hikma which
is 239,385,501 Shares following the release
of the LTIP 2013.
* Said Darwazah has a direct interest in Hikma
of 745,383 Shares and an effective interest
in Hikma through his interest in Darhold Limited
of 12,520,501 Shares. Mazen Darwazah has a direct
interest in Hikma of 952,965 Shares and an effective
interest in Hikma through his interest in Darhold
Limited of 6,303,166 Shares.
- ENDS -
Enquiries
Peter Speirs +44 20 7399 2760
Company Secretary, Hikma Pharmaceuticals PLC
About Hikma
Hikma Pharmaceuticals PLC is a fast growing pharmaceutical group
focused on developing, manufacturing and marketing a broad range of
both branded and non-branded generic and in-licensed products.
Hikma's operations are conducted through three businesses:
"Branded", "Injectables" and "Generics" based primarily in the
Middle East and North Africa ("MENA") region, where it is a market
leader, the United States and Europe.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHGCGDUSBBBGLC
(END) Dow Jones Newswires
May 19, 2016 05:17 ET (09:17 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024